MDKM Mdechem Inc (CE)

MDEChem, Inc. (PINK SHEETS: MDKM) a research and development company is pleased to announce that it will be holding its Annual Meeting on May 20th at the Comfort Suites Hotel in Houston (Richmond & Fountainview Drives) 713-787-0004. The meeting is open to all shareholders and is scheduled to start at 9:00AM and end at 11:30AM. The Company intends to update shareholders as to the progress that is being made with various aspects of the business including an update on EnviroFuels L.P. sales, marketing and testing efforts. Director nominations and the election of Directors will take place at this meeting. The Company is on track to commence the marketing of its Maxheal product line in the United States. The Maxheal line of products has been registered and marketed in Costa Rica for the past 5 years. 5 years is a benchmark requirement for OTC products in order to be marketed in the United States. Maxheal is an anti-bacterial and wound healing agent used in first aid occurrences. It has been marketed through MDEChem's Costa Rican subsidiary, Med Quimica S.A. of San Jose, Costa Rica. Clinical studies currently under way by Dr. Enrique Feoli continue to yield support to the "proof of concept" on the potential use of MDECHEM's active ingredient for asthma control, sports medicine and for periodontal uses. This Maxheal can be found in the main pharmacies of Costa Rica and some other niches. The Maxheal has gained a favorable presence in the marketplace and a solid reputation of being a high quality and very efficacious product. MDEChem is currently reworking on the Maxheal website. The website: www.maxhealcr.com will be posted by June 10th, 2005. The site will be in English and Spanish. MDEChem and its Directors appreciate the continued patience of its shareholders during the time it has taken to market the results of its Research & Development (R&D) efforts. NOTE: Safe Harbor Statements may contain "forward looking statements" under the Private Securities Litigation Reform Act of 1995. This announcement may contain "forward looking" statements. Although we believe that the statements contained herein are reasonable, no assurance can be guaranteed as to their accuracy, authenticity or prove correct. Always consult an Investment Advisor prior to investing.